Carpenter S P, Lasker J M, Raucy J L
College of Pharmacy, University of New Mexico, Albuquerque 87131, USA.
Mol Pharmacol. 1996 Feb;49(2):260-8.
The mechanisms responsible for ethanol-mediated teratogenesis have not been resolved. However, possible etiologies include the local formation of the teratogen acetaldehyde or oxygen radicals by fetal ethanol-oxidizing enzymes. As alcohol dehydrogenases are expressed at very low concentrations in human embryonic tissues, the ethanol-inducible P450 enzyme, CYP2E1, could be the sole catalyst of fetal ethanol oxidation. With this in mind, we examined the expression of this P450 in liver samples from fetuses ranging in gestational age from 16 to 24 weeks. Immunoblot analysis of fetal liver microsomes revealed the presence of a protein immunoreactive with CYP2E1 antibodies that exhibited a slightly lower molecular weight than that found in adult liver samples. Embryonic CYP2E1 expression was further confirmed by the reverse transcriptase reaction with RNA from a 19-week gestational fetal liver used as template. Catalytic capabilities of human fetal microsomes were assessed by measurement of the rate of ethanol oxidation to acetaldehyde, which were 12-27% of those exhibited by adult liver microsomes. Immunoinhibition studies with CYP2E1 antibodies revealed that the corresponding antigen was the major catalyst of this reaction in both fetal and adult tissues. We then assessed whether embryonic CYP2E1 was, like the adult enzyme, inducible by xenobiotics. Treatment of primary fetal hepatocyte cultures with either ethanol or clofibrate demonstrated a 2-fold increase in CYP2E1 levels compared with untreated cells. Collectively, our results indicate that CYP2E1 is present in human fetal liver, that the enzyme is functionally similar to CYP2E1 from adults, and that fetal hepatocyte CYP2E1 is inducible in culture by xenobiotics, including ethanol. Because fetal CYP2E1 mediates ethanol metabolism, the enzyme may play a pivotal role in the local production of acetaldehyde and free radicals, both of which have potential deleterious effects on the developing fetus.
乙醇介导的致畸作用机制尚未明确。然而,可能的病因包括胎儿乙醇氧化酶使致畸剂乙醛或氧自由基在局部形成。由于酒精脱氢酶在人类胚胎组织中的表达浓度极低,乙醇诱导型细胞色素P450酶CYP2E1可能是胎儿乙醇氧化的唯一催化剂。考虑到这一点,我们检测了孕龄在16至24周的胎儿肝脏样本中这种细胞色素P450的表达。对胎儿肝脏微粒体进行免疫印迹分析发现,存在一种与CYP2E1抗体发生免疫反应的蛋白质,其分子量略低于成人肝脏样本中的该蛋白质。以19周孕龄胎儿肝脏的RNA为模板进行逆转录反应,进一步证实了胚胎CYP2E1的表达。通过测量乙醇氧化为乙醛的速率来评估人胎儿微粒体的催化能力,其速率为成人肝脏微粒体的12%至27%。用CYP2E1抗体进行的免疫抑制研究表明,相应抗原是胎儿和成人组织中该反应的主要催化剂。然后,我们评估胚胎CYP2E1是否像成人酶一样可被外源化学物诱导。用乙醇或氯贝丁酯处理原代胎儿肝细胞培养物后发现,与未处理的细胞相比,CYP2E1水平增加了两倍。总体而言,我们的结果表明,CYP2E1存在于人类胎儿肝脏中,该酶在功能上与成人的CYP2E1相似,并且胎儿肝细胞CYP2E1在培养中可被包括乙醇在内的外源化学物诱导。由于胎儿CYP2E1介导乙醇代谢,该酶可能在乙醛和自由基的局部产生中起关键作用,而这两者对发育中的胎儿都有潜在的有害影响。